Sunitinib and Everolimus in Pancreatic Neuroendocrine Tumors

Moertel C.G. , Lefkopoulo M. , Lipsitz S. , Hahn R.G. , Klaassen D. : Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet cell carcinoma. N Engl J Med, 326: 519–523, 1992.

Kulke M.H. , Siu L.L. , Tepper J.E. , Fisher G. , Jaffe D. , Haller D.G. , Ellis L.M. , Benedetti J.K. , Bergsland E.K. , Hobday T.J. , Van Cutsem E. , Pingpank J. , Oberg K. , Cohen S.J. , Posner M.C. , Yao J.C. : Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute neuroendocrine tumor clinical trials planning meeting. J Clin Oncol, 29: 934–943, 2011.

Rinke A. , Ricci S. , Bajetta E. , Jelic S. : Pharmacological therapy of neuroendocrine tumors. Tumori, 96: 847–857, 2010.

Della Torre S. , Procopio G. , Fusi A. , Catena L. , Ferrari L. , Nova P. , Denaro A. , Bichisao E. , Bajetta E. : Current treatments of neuroendocrine tumors role of biotherapy and chemotherapy. Tumori, 89: 111–116, 2003.

Raymond E. , Dahan L. , Raoul J.L. , Bang Y.J. , Borbath I. , Lombard-Bohas C. , Valle J. , Metrakos P. , Smith D. , Vinik A. , Chen J.S. , Hörsch D. , Hammel P. , Wiedenmann B. , Van Cutsem E. , Patyna S. , Lu D.R. , Blanckmeister C. , Chao R. , Ruszniewski P. : Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med, 364: 501–513, 2011.

Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K; RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group: Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med, 364: 514–523, 2011.